Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Middle molecules re-examined

L W Henderson

    Nephron
    |January 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    This review examines middle molecules in uremia. Evidence supports their presence and significant role in the disease

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Treatment of barbiturate intoxication with a report of recent experience at Peter Bent Brigham Hospital.

    Annals of internal medicine·2013
    Same author

    Blood purification by ultrafiltration and fluid replacement (diafiltration).

    Hemodialysis international. International Symposium on Home Hemodialysis·2009
    Same author

    The inadequacy of Kt/V(urea): a brief history of time.

    Hemodialysis international. International Symposium on Home Hemodialysis·2009
    Same author

    The birth of hemodiafiltration.

    Contributions to nephrology·2007
    Same author

    Quantification of middle molecular weight solute removal in dialysis.

    Seminars in dialysis·2001
    Same author

    Renal versus continuous versus intermittent therapies for removal of uremic toxins.

    Kidney international. Supplement·2001

    Area of Science:

    • Nephrology
    • Uremic Toxin Research

    Background:

    • Uremia is a complex syndrome associated with chronic kidney disease.
    • The role of various uremic toxins, including middle molecules, is under investigation.

    Purpose of the Study:

    • To review existing evidence regarding the presence and pathophysiologic importance of middle molecules in uremia.
    • To synthesize findings to determine the significance of middle molecules in uremic pathology.

    Main Methods:

    • Comprehensive literature review of studies investigating middle molecules in uremia.
    • Analysis of evidence supporting or refuting the presence and role of these molecules.

    Main Results:

    • Evidence supports the presence of middle molecules in uremic patients.
    • The findings indicate that middle molecules are pathogenetically important in uremia.

    Conclusions:

    • Middle molecules are present in uremia.
    • The evidence strongly favors the pathophysiologic importance of middle molecules in the progression of uremic disease.